Prostatic Artery Embolization for The Treatment of Benign Prostatic Obstruction - A Retrospective Review of The Novel Experience Of 2 Tertiary Urology Centers
DOI:
https://doi.org/10.32896/tij.v3n1.1-9Keywords:
Benign Prostatic Hyperplasia, Prostate, EmbolizationAbstract
Background: Benign Prostatic Hyperplasia (BPH) is common in aging men with worldwide prevalence at 20-62%, while Malaysian prevalence was 39.3% (2001) and increased at 8% per decade. In surgical treatment of BPH, Trans-Urethral Resection of Prostate (TURP) remains the gold standard. Other surgical options would mostly also require general anesthesia (GA). Therefore, more Local-Anaesthesia (LA) based options should be made available for patients who are not fit or unwilling to be under GA. Those currently available LA-based procedure has shown promising results including prostatic stents and trans-urethral lifts, but have drawbacks due to being expensive, not widely available, less suitable in median lobe enlargement or may cause complications including migration, overgrowth of prostatic tissue or foreign-body related complications which may require GA for their treatment. Prostatic Artery Embolization (PAE), initially an LA-based emergency treatment option for persistent life-threatening hematuria from a bleeding BPH, now has been proven to be a safe elective treatment. In Malaysia this novel technique was first reported in 2017 for treatment of post TURP intractable hematuria.
Methods and Material: We retrospectively evaluated all 13 catheter-dependent BPH patients in two tertiary urology centres treated with PAE from April 2019 until December 2021 to assess post-treatment efficacy.
Results: One patient failed removal of catheter within 3 months post-procedure but 12 out of 13 patients safely got their catheter removed within 1-3 months and resulted in significant IPSS improvement.
Conclusion: PAE is a safe and effective treatment option for BPH patients of the Malaysian population but needs prospective evaluation.
References
American Urological Association (AUA). (2019)
EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2022.
Mohamad Anuar MF, Solihin Rezali M, Mohamed Daud MA, Ismail SB. A community-based study on lower urinary tract symptoms in Malaysian males aged 40 years and above. Scientific Reports. 2022 Feb;12(1):2345.
Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian Journal of Urology. 2017 Jul;4(3):148-51.
Forster LR, Watson L, Breeze CE, Di Benedetto A, Graham S, Patki P, et al. The Fate of Ureteral Memokath Stent(s) in a High-Volume Referral Center: An Independent Long-Term Outcomes Review. Journal of Endourology. 2021 Feb;35(2):180-6
Sethi K, Bozin M, Jabane T, McMullin R, Cook D, Forsyth R, et al. Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: An underutilized procedure? Investig Clin Urol 2017 Nov;58(6):447-52
Eaton Turner E, Jenks M, McCool R, Marshall C, Millar L, Wood H, et al. The Memokath-051 Stent for the Treatment of Ureteric Obstruction: A NICE Medical Technology Guidance. Applied Health Economics and Health Policy. 2018 Aug;16(4):445–64.
Jones P, Rai BP, Aboumarzouk O, Somani BK. UroLift: A new minimally-invasive treatment for benign prostatic hyperplasia. Therapeutic Advances in Urology. 2016 Dec;8(6):372-6.
Loloi J, Feiertag N, Gautam K, Maria P. An update on the outcomes of patients treated with urolift for benign prostatic hyperplasia. Research and Reports in Urology 2021 Jun 11;13:347–55.
Gratzke C, Barber N, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2017 May;119(5):767-75.
Maclean D, Maher B, Modi S, Harris M, Dyer J, Somani B, et al. Prostate artery embolization: A new, minimally invasive treatment for lower urinary tract symptoms secondary to prostate enlargement. Therapeutic Advances in Urology. 2017 Jul 10;9(8):209-16.
Mitchell ME, Waltman AC, Athanasoulis CA, Kerr WS, Dretler, SP. Control of Massive Prostatic Bleeding with Angiographic Techniques. Journal of Urology. 1976 Jun;115(6):692-5.
Yu H, Isaacson AJ, Burke CT. Review of Current Literature for Prostatic Artery Embolization. Semin Intervent Radiol. 2016 Sep;33(3):231-5.
Young S, Golzarian J. Prostate embolization: patient selection, clinical management and results. CVIR Endovascular. 2019 Jan 18;2(1):7.
Darewicz J, Cylwik B, Musierowicz A, Boczon S. The effect of internal iliac artery embolization of the prostatic gland in the dog. International Urology and Nephrology. 1980;12(1):37–41.
DeMeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of Benign Prostatic Hyperplasia-related Bladder Outlet Obstruction after Transarterial Polyvinyl Alcohol Prostate Embolization. Journal of Vascular and Interventional Radiology. 2000 Jun;11(6):767–70.
Carnevale FC, Antunes AA, da Motta Leal Filho JM, de Oliveira Cerri LM, Baroni RH, Marcelino AS, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: Preliminary results in two patients. Cardiovascular and Interventional Radiology. 2010 Apr;33(2):355-61.
Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, Oliveira AG, et al. Prostatic Arterial Embolization to Treat Benign Prostatic Hyperplasia. Journal of Vascular and Interventional Radiology. 2011 Jan;22(1):11-19.
Zhou Z, Gao Z, Wu J, Cui Y. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis. World Journal of Urology. 2020 Aug;38(8):2069-70.
Young S, Golzarian J. Prostate embolization: patient selection, clinical management and results. CVIR Endovascular. 2019 Jan 18;2(1):7.
Teichgräber U, Aschenbach R, Diamantis I, von Rundstedt FC, Grimm MO, Franiel T. Prostate Artery Embolization: Indication, Technique and Clinical Results. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren. 2018 Sep;190(9):847-55.
Petrillo M, Pesapane F, Fumarola EM, Emili I, Acquasanta M, Patella F, et al. State of the art of prostatic arterial embolization for benign prostatic hyperplasia. Gland Surgery. 2018 Apr;7(2):188-99.
Hayati F, Abidin ZAZ, Kadir F, Ismail NAN, Hee TG. Transüretral prostat rezeksiyonuyşla ilişkili kanamada embolizasyon: Endovasküler teknikte ilerleme. Medeni Med J. 2017;32:123-7.
Teh GC, Sahabudin RM, Lim TC, Chong WL, Woo S, Mohan M, et al. Prevalence of Symptomatic BPE Among Malaysian Men Aged 50 and Above Attending Screening During Prostate Health Awareness Campaign. The Medical Journal of Malaysia. 2001 Jun;56(2):186-95.
Ray AF, owell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int 2018 Aug;122(2):270-82.
Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kesseler TM, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: Randomised, open label, non-inferiority trial. BMJ [Internet]. 2018;361.
Abdul Rahim E, Abdul Rahim A, Huddin AB, Nik Ismail NA, Mohd Yakob, MN. Embozene loaded prostatic artery embolization. Malaysian Journal of Medicine and Health Sciences. 2020 Sept;16(3):313-5
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
